PF
PFIZER INC
PFE Health Care · Pharmaceuticals & Biotechnology
Latest period 2026-06-28 · 38 filings on record
SHOWING
Fiscal years as the company filed them — each point is one closed year from its 10-K, ending on that year's own close. A year with no 10-K on file is assembled from its four quarters and labelled by its ending date instead; a year still open gets no column at all.
Ranked against Health Care · 51 peers
Each grade is a single reported quarter's assessment, never an average — a card shows the grade at the newest quarter in view, so it follows the period and range controls above. Latest scored quarter: 2026-06-28.
Growth
4th pct
▲+1 over range · as of 2025-12-31
Quality
23rd pct
▲+12 over range · as of 2025-12-31
Safety
19th pct
▲+15 over range · as of 2025-12-31
OVERVIEWYoY Δ
Latest fiscal year · ending 2025-12-31 · green = improving · click a row to chart it
Revenue $62.6B −1.6% Gross margin 74.3% +2.4pp Operating margin — — Net margin 12.4% −0.2pp Net income $7.8B −3.2%
Debt / equity
0.74
+3.6%
EPS (diluted)
$1.36
−3.5%
EBITDA
—
—
Filings
FY 2021 → FY 2025 · following the period bar 5 match| Year | Q1 | Q2 | Q3 | FY |
|---|---|---|---|---|
| 2025 | 10-Q Q1 2025 | 10-Q Q2 2025 | 10-Q Q3 2025 | 10-K FY 2025 |
| 2024 | 10-Q Q1 2024 | 10-Q Q2 2024 | 10-Q Q3 2024 | 10-K FY 2024 |
| 2023 | 10-Q Q1 2023 | 10-Q Q2 2023 | 10-Q Q3 2023 | 10-K FY 2023 |
| 2022 | 10-Q Q1 2022 | 10-Q Q2 2022 | 10-Q Q3 2022 | 10-K FY 2022 |
| 2021 | 10-Q Q1 2021 | 10-Q Q2 2021 | 10-Q Q3 2021 | 10-K FY 2021 |
Filing-level fact detail is a Pro feature. The grades and figures above are free. See Pro plans
Trends
Fiscal years as the company filed them
Revenue
| Period | Period end | Revenue |
|---|---|---|
| FY 2021 | 2021-12-31 | $81.3B |
| FY 2022 | 2022-12-31 | $101.2B |
| FY 2023 | 2023-12-31 | $59.6B |
| FY 2024 | 2024-12-31 | $63.6B |
| FY 2025 | 2025-12-31 | $62.6B |
Net income
| Period | Period end | Net income |
|---|---|---|
| FY 2021 | 2021-12-31 | $22.0B |
| FY 2022 | 2022-12-31 | $31.4B |
| FY 2023 | 2023-12-31 | $2.1B |
| FY 2024 | 2024-12-31 | $8.0B |
| FY 2025 | 2025-12-31 | $7.8B |
ZOOM
FY 2019
FY 2025
Grade history
Point-in-time: each period shows the grade of the quarter it ends at — grades are never summed or averaged across a window.
Growth
4
Quality
23
Safety
19
Hover to read every grade at a period · shared with the trends chart · axis fixed 0–100
| Period | Period end | Growth | Quality | Safety |
|---|---|---|---|---|
| FY 2021 | 2021-12-31 | not scored | not scored | not scored |
| FY 2022 | 2022-12-31 | not scored | not scored | not scored |
| FY 2023 | 2023-12-31 | 3 | 11 | 4 |
| FY 2024 | 2024-12-31 | 92 | 29 | 26 |
| FY 2025 | 2025-12-31 | 4 | 23 | 19 |